Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ACTRN12626001189314) titled 'Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults (SACHA)' on Sept. 24.
Study Type: Observational
Study Design:
Purpose: Natural history
Duration: Longitudinal
Selection: Defined population
Timing: Prospective
Primary Sponsor: Australian and New Zealand Children's Haematology/ Oncology Group
Condition:
Paediatric Cancer
Cancer
Paediatric Cancer
Cancer
Cancer - Children's - Other
Cancer - Any cancer
Intervention:
This prospective observational, international registry includes children, adolescents and young adults aged 0-25 years with a paediatr...